Previous close | 2.5500 |
Open | N/A |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 16.00 |
Expiry date | 2024-11-15 |
Day's range | 2.5500 - 2.5500 |
Contract range | N/A |
Volume | |
Open interest | 1 |
Dr. Reddy's (RDY) is set to acquire Haleon's leading global NRT brand, Nicotinell, and its related portfolio across all formats of the drug for GBP 500 million to boost its OTC presence worldwide.
Novo Nordisk (NVO) declines as a late-stage study of its uncontrolled hypertension and advanced chronic kidney disease candidate, ocedurenone, fails to achieve the primary goal.
ImmunityBio (IBRX) rises 17% in the past week as it announces insurance coverage as well as the treatment of the first patients with its newly approved bladder cancer immunotherapy, Anktiva.